B60.19
Other acanthamebic disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Other acanthamebic disease (ICD-10 code B60.19) refers to infections caused by amoebae belonging to the Acanthamoeba genus that do not fit into more specific categories. These microscopic organisms are commonly found in water, soil, and other environmental sources. While most people are exposed to Acanthamoeba without any health issues, in some cases, especially among immunocompromised individuals, these amoebae can cause serious infections. Such infections can affect the eyes, skin, brain, or other tissues, depending on how the organism enters the body.
Causes & Symptoms
Clinical Causes: Exposure to contaminated water, especially in contact lens solutions and tap water. Injuries or cuts that expose the skin or other tissues to contaminated sources. Immunocompromised states, such as HIV/AIDS, cancer, or after organ transplantation, which increase susceptibility. Poor hygiene or inadequate contact lens cleaning practices.
Key Symptoms: Eye infections, which can cause pain, redness, blurred vision, and sensitivity to light. Skin lesions or ulcers that may be painful or itchy. Infections of the brain (granulomatous amoebic encephalitis) leading to headaches, fever, neurological deficits, and altered mental state. Other tissue infections that may cause swelling, pain, or fever depending on the site involved.
Diagnostic & Treatment
Diagnosis Path: Microscopic examination of tissue samples, eye swabs, or cerebrospinal fluid. Culture of samples in specific media to identify Acanthamoeba. Polymerase chain reaction (PCR) tests that detect Acanthamoeba DNA. Imaging studies like MRI or CT scans if brain involvement is suspected. Histopathological analysis to observe amoebae in tissue specimens.
Treatment Protocols: Antiprotozoal medications such as propamidine isethionate, chlorhexidine, or other specific agents aimed at eradicating the amoebae. Supportive therapy to manage symptoms and prevent complications. Surgical intervention in cases of severe tissue damage or eye infections, like keratitis or stromal ulcers. Management of underlying immune conditions to help control infection. Close monitoring by healthcare professionals throughout treatment to assess response and potential side effects.
Clinical Advice & FAQs
Billing Guidance
Is B60.19 a billable ICD-10 code?
Yes, B60.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B60.19?
Clinical documentation must specify the nature of Other acanthamebic disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
